OpGen.jpg
OpGen Reports First Quarter 2023 Financial Results and Provides Business Update
15 mai 2023 16h15 HE | OpGen, Inc.
Total revenue for the first quarter of 2023 was approximately $0.91 million, an increase of approximately 94% compared to the first quarter of 2022Expanded U.S. growth opportunities with the Unyvero...
OpGen.jpg
OpGen’s Subsidiary Curetis Meets All Remaining Key Milestones in R&D Collaboration with FIND
26 avr. 2023 16h30 HE | OpGen, Inc.
Triggers milestone payment of approximately $0.3 million ROCKVILLE, Md., April 26, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company...
OpGen.jpg
OpGen to Provide Business Update and Financial Results for the Fourth Quarter and Full Year 2022 on March 29th at 4:30 p.m. Eastern Time
22 mars 2023 07h30 HE | OpGen, Inc.
ROCKVILLE, Md., March 22, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its fourth quarter...
Reports Insights Logo.jpg
Magnetic Sensor Market Poised to Reach US$7.5 Bn By 2030, Expand at 7.2% CAGR
07 mars 2023 02h00 HE | REPORTSINSIGHTS CONSULTING PVT LTD
New York, March 07, 2023 (GLOBE NEWSWIRE) -- The detailed research report on the magnetic sensor market is offered by Reports Insights Pvt. Ltd.  The research takes into consideration several...
OpGen.jpg
OpGen Subsidiary Ares Genetics Announces its Move to New Vienna Location and Provides Update on Business Growth
01 mars 2023 07h30 HE | OpGen, Inc.
Approximately 5,000 sq. ft. facility houses laboratory and administrative operations under one location for future growth of businessARESdb, the company’s AMR knowledge database, has grown by 28% in...
Selux Diagnostics
Healthcare Industry Veteran Jamie Condie Joins Selux Diagnostics' Board of Directors
14 févr. 2023 07h30 HE | Selux Diagnostics
BOSTON, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced today that...
BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
BioAegis Therapeutics Announces FDA Clearance of IND for its ‘Inflammation Regulator Protein,’ Gelsolin, for the Treatment of ARDS
26 janv. 2023 14h05 HE | BioAegis Therapeutics
NORTH BRUNSWICK, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage company developing therapies for inflammatory diseases through a portfolio built around plasma...
Selux Diagnostics
FDA Clears 'Selux NGP System' for Rapid Antibiotic Susceptibility Testing
19 janv. 2023 07h00 HE | Selux Diagnostics
BOSTON, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced it has received...
BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
BioAegis Leverages Gelsolin’s Broad Therapeutic Applicability by Expanding into Multiple Inflammatory Diseases
06 janv. 2023 14h50 HE | BioAegis Therapeutics
NORTH BRUNSWICK, N.J., Jan. 06, 2023 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, Inc., a clinical-stage company developing therapies for inflammatory diseases through a portfolio built around plasma...
cmi_logo.png
[Latest] Global Smart Electric Meter Market Size/Share Worth USD 55.2 Billion by 2030 at a 10.75% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
05 déc. 2022 09h30 HE | Custom Market Insights
Sandy, Utah, USA, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Smart Electric Meter Market Size, Trends and Insights By Technology (AMI, RF,...